In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.
Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters ...
WASHINGTON (AP) — U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans — and removed one of the two vaccines available for young children. The new shots ...
A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to review data on the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, with a vote expected on ...
The Food and Drug Administration (FDA) on Wednesday approved the updated version of Pfizer’s and Moderna’s COVID-19 vaccines for this upcoming respiratory viral season, but limited the approval to ...
The U.S. Food and Drug Administration has approved emergency use authorization for a booster shot of the Pfizer-BioNTech vaccine to be given at least six months after completion of the second dose for ...
President Trump and Pfizer are set to unveil a new website for Americans today, and lower medication costs. What is it? What ...
U.S. regulators approved Pfizer’s updated COVID-19 shot Wednesday but with limits that could complicate access for millions of American adults and children.Pfizer said in a release its vaccine is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results